Subependymomas: Clinical, Radiological Characteristics, and Surgical Outcomes

Authors

Javier Toledo, Clemente Alvarez Emergency Hospital, Rosario, Santa Fe, ArgentinaFollow
Juan M. Gil, Sanatorio Parque, Rosario, Santa Fe, Argentina
José Nallino, Sanatorio Parque, Rosario, Santa Fe, Argentina

Document Type

Original Article

Abstract

Introduction: Since their first description in 1945 by Sheinker, subependymomas have been reported in various series, but none with large numbers of patients. In this article, we present a series of nine cases of subependymomas treated at our institution. We examine the presentation, radiological and histological findings, treatments, and long-term follow-up in each case.

Methods: We retrospectively analyzed nine cases of subependymomas operated on at our institution between 1998 and 2019. Variables of interest included age, sex, initial manifestation, tumor size, location, extent of resection, short-term clinical evolution, and survival. Tumor size was calculated using the maximum diameter on MRI. The extent of resection was classified as total, subtotal, or partial.

Results: The mean age of the series was 50.75 years, with a range between 30 and 67 years. The male-to-female ratio was 1.25, favoring males. Micro-surgical techniques with classic approaches based on tumor location were used in all cases. The tumor locations were: fourth ventricle (67%), lateral ventricles (22%), and medullary (11%). There were no cases of death, and total resection was achieved in all patients. No recurrences were found during long-term follow-up (average of 9 years).

Conclusion: Subependymomas are benign neoplasms for which surgical treatment presents excellent long-term results with good clinical outcomes

Recommended Citation

Toledo, Javier; Gil, Juan M.; and Nallino, José (2024) "Subependymomas: Clinical, Radiological Characteristics, and Surgical Outcomes," LATIN Neurosurgery Journal: Vol. 1: Iss. 2, Article 11.
Available at: https://www.latin-neurosurgery.org/home/vol1/iss2/11

References

[1] I Mark Scheinker. Subependymoma: a newly recognized tumor of subependymal derivation. Journal of neurosurgery, 2(3):232–240, 1945.

[2] Amit Jain, Anubhav G Amin, Punya Jain, Peter Burger, George I Jallo, Michael Lim, and Chetan Bettegowda. Subependymoma: clinical features and surgical outcomes. Neurological research, 34(7):677–684, 2012.

[3] Elisabeth J Rushing, Patrick B Cooper, Martha Quezado, Maria Begnami, Ana Crespo, James G Smirniotopoulos, James Ecklund, Cara Olsen, and Mariarita Santi. Subependymoma revisited: clinicopathological evaluation of 83 cases. Journal of neuro-oncology, 85:297–305, 2007.

[4] International Agency for Research on Cancer and Otmar D. Wiestler. WHO Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer, 2016.

[5] Ignacio J. Barrenecheal, Nestor Yunisl, Daniel ´ Rovira, and Jose Carlos Nallino. Subependi- ´ moma sintomatico del piso del iv ventr ´ ´ıculo: reporte de un caso y revision de la literatura. ´ Revista Argentina de Neurolog´ıa, Psiquiatr´ıa y Neurocirug´ıa, 25:39––41, 2011.

[6] Bernd W Scheithauer. Symptomatic subependymoma: report of 21 cases with review of the literature. Journal of neurosurgery, 49(5):689–696, 1978.

[7] Clifton Fuller. WHO Classification of Tumours of the Central Nervous System, Fourth Edition. Journal of Neuropathology & Experimental Neurology, pages 260–260, 2008. Available from: http://dx.doi.org/10.1097/nen. 0b013e31816b937a.

[8] Richard A Prayson and John H Suh. Subependymomas: clinicopathologic study of 14 tumors, including comparative mib-1 immunohistochemical analysis with other ependymal neoplasms. Archives of Pathology and Laboratory Medicine, 123(4):306–309, 1999.

[9] Daniela Lombardi, Bernd W Scheithauer, Fredric B Meyer, Glenn S Forbes, Edward G Shaw, Donna J Gibney, and Jerry A Katzmann. Symptomatic subependymoma: a clinicopathological and flow cytometric study. Journal of neurosurgery, 75(4):583–588, 1991.

[10] MV Chiechi, JG Smirniotopoulos, and RV Jones. Intracranial subependymomas: Ct and mr imaging features in 24 cases. AJR. American journal of roentgenology, 165(5):1245–1250, 1995.

[11] Zhiyong Bi, Xiaohui Ren, Junting Zhang, and Wang Jia. Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma. Journal of neurosurgery, 122(1):49–60, 2015.

[12] C Hoeffel, M Boukobza, M Polivka, G Lot, JP Guichard, F Lafitte, D Reizine, and JJ Merland. Mr manifestations of subependymomas. American journal of neuroradiology, 16(10):2121–2129, 1995.

[13] Robert Seltman, Aaron Kamer, and Aaron Cohen-Gadol. Subependymoma. http://dx.doi.org/10.18791/nsatlas. v1.03.01.39, 2017.

[14] M. Gazi Yas¸argil, M. Yas¸argil, and Saleem I. Abdulrauf. Surgery of intraventricular tumors. Neurosurgery, pages SHC1029–41, 2008. Available from: http://dx.doi.org/ 10.1227/01.neu.0000333768.12951.9a.

[15] Michael R Gaab and Henry WS Schroeder. Neuroendoscopic approach to intraventricular lesions. Journal of neurosurgery, 88(3):496– 505, 1998